Hans-Peter Gschwind

560 total citations
15 papers, 466 citations indexed

About

Hans-Peter Gschwind is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Hans-Peter Gschwind has authored 15 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Hans-Peter Gschwind's work include Colorectal Cancer Treatments and Studies (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Iron Metabolism and Disorders (2 papers). Hans-Peter Gschwind is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Iron Metabolism and Disorders (2 papers). Hans-Peter Gschwind collaborates with scholars based in Switzerland, United States and United Kingdom. Hans-Peter Gschwind's co-authors include Markus Zollinger, Felix Waldmeier, Gerhard Groß, Michael Seiberling, Michael Hayes, Rolf Pokorny, Monique Ben‐Am, Ulrike Pfaar, Peter Zbinden and Bin Peng and has published in prestigious journals such as European Journal of Biochemistry, Drug Metabolism and Disposition and The Journal of Steroid Biochemistry and Molecular Biology.

In The Last Decade

Hans-Peter Gschwind

15 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans-Peter Gschwind Switzerland 10 181 148 105 97 54 15 466
Ulrike Pfaar Switzerland 10 190 1.0× 131 0.9× 89 0.8× 201 2.1× 63 1.2× 12 568
Martine Hubert France 12 120 0.7× 153 1.0× 88 0.8× 184 1.9× 52 1.0× 15 591
Greta Cipriani Italy 7 166 0.9× 91 0.6× 69 0.7× 325 3.4× 25 0.5× 7 529
Tokiko Nakamura Japan 7 115 0.6× 165 1.1× 89 0.8× 49 0.5× 35 0.6× 20 517
Naoaki Murao Japan 15 205 1.1× 97 0.7× 68 0.6× 161 1.7× 41 0.8× 26 624
Guowei Dai China 9 268 1.5× 156 1.1× 55 0.5× 68 0.7× 12 0.2× 18 451
Noelia Nebot United States 11 180 1.0× 55 0.4× 94 0.9× 164 1.7× 10 0.2× 17 432
Brad Hirakawa United States 10 318 1.8× 50 0.3× 27 0.3× 133 1.4× 32 0.6× 18 566
Michael W. Lago United States 10 209 1.2× 161 1.1× 115 1.1× 93 1.0× 58 1.1× 13 538
Tetsuo Asaki Japan 11 163 0.9× 245 1.7× 189 1.8× 81 0.8× 127 2.4× 14 658

Countries citing papers authored by Hans-Peter Gschwind

Since Specialization
Citations

This map shows the geographic impact of Hans-Peter Gschwind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans-Peter Gschwind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans-Peter Gschwind more than expected).

Fields of papers citing papers by Hans-Peter Gschwind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans-Peter Gschwind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans-Peter Gschwind. The network helps show where Hans-Peter Gschwind may publish in the future.

Co-authorship network of co-authors of Hans-Peter Gschwind

This figure shows the co-authorship network connecting the top 25 collaborators of Hans-Peter Gschwind. A scholar is included among the top collaborators of Hans-Peter Gschwind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans-Peter Gschwind. Hans-Peter Gschwind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Laborde, Laurent, Dario Sterker, Hans-Peter Gschwind, et al.. (2018). Continuous low-dose infusion of patupilone increases the therapeutic index in mouse and rat tumour models. Anti-Cancer Drugs. 29(7). 691–701. 1 indexed citations
2.
Blanckenburg, Friedhelm von, Marcus Oelze, Dietmar G. Schmid, et al.. (2014). An iron stable isotope comparison between human erythrocytes and plasma. Metallomics. 6(11). 2052–2061. 23 indexed citations
3.
Gschwind, Hans-Peter, Dietmar G. Schmid, Friedhelm von Blanckenburg, et al.. (2014). Iron uptake and ferrokinetics in healthy male subjects of an iron-based oral phosphate binder (SBR759) labeled with the stable isotope58Fe. Metallomics. 6(11). 2062–2071. 4 indexed citations
4.
Walles, Markus, Yi Jin, M. RITZAU, et al.. (2013). Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects. Drug Metabolism and Disposition. 41(9). 1626–1641. 23 indexed citations
5.
Gschwind, Hans-Peter, Ulrike Glaenzel, Felix Waldmeier, et al.. (2012). Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitro. European Journal of Pharmaceutical Sciences. 47(1). 44–55. 5 indexed citations
6.
7.
O’Reilly, Terence, Paul M.J. McSheehy, R. Kawai, et al.. (2009). Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents. Cancer Chemotherapy and Pharmacology. 65(4). 625–639. 55 indexed citations
8.
Gschwind, Hans-Peter, Felix Waldmeier, Markus Zollinger, Alain Schweitzer, & Maximilian A. Grassberger. (2007). Pimecrolimus: Skin disposition after topical administration in minipigs in vivo and in human skin in vitro. European Journal of Pharmaceutical Sciences. 33(1). 9–19. 18 indexed citations
9.
Jost, Lorenz, Hans-Peter Gschwind, T. Jalava, et al.. (2006). Metabolism and Disposition of Vatalanib (PTK787/ZK-222584) in Cancer Patients. Drug Metabolism and Disposition. 34(11). 1817–1828. 60 indexed citations
10.
Gschwind, Hans-Peter, Ulrike Pfaar, Felix Waldmeier, et al.. (2005). METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS. Drug Metabolism and Disposition. 33(10). 1503–1512. 186 indexed citations
11.
Knoblich, Juergen A., Päivi M. Paldánius, Hans-Peter Gschwind, et al.. (2003). 561 Clinical results from an ADME (absorption, distribution, metabolism, and excretion) trial of PTK787/ZK 222584 (PTK/ZK): a novel, oral angiogenesis inhibitor in patients with advanced cancer. European Journal of Cancer Supplements. 1(5). S170–S170. 1 indexed citations
12.
Lønning, Per Eystein, Jürgen Geisler, Dag Clement Johannessen, et al.. (2001). Pharmacokinetics and metabolism of formestane in breast cancer patients. The Journal of Steroid Biochemistry and Molecular Biology. 77(1). 39–47. 21 indexed citations
13.
Gschwind, Hans-Peter, et al.. (1992). Absorption and disposition of14C-labelled oxiracetam in rat, dog and man. European Journal of Drug Metabolism and Pharmacokinetics. 17(1). 67–82. 3 indexed citations
14.
Kaiser, G., Roland Ackermann, Hans-Peter Gschwind, et al.. (1990). The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride. Biopharmaceutics & Drug Disposition. 11(9). 753–764. 12 indexed citations
15.
Gschwind, Hans-Peter, et al.. (1979). Affinity Chromatography of Tryptophan Synthase fromEscherichia coli. European Journal of Biochemistry. 96(2). 403–416. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrike Pfaar Breakdown of academic impact, for papers by Martine Hubert Breakdown of academic impact, for papers by Greta Cipriani Breakdown of academic impact, for papers by Tokiko Nakamura Breakdown of academic impact, for papers by Naoaki Murao Breakdown of academic impact, for papers by Guowei Dai Breakdown of academic impact, for papers by Noelia Nebot Breakdown of academic impact, for papers by Brad Hirakawa Breakdown of academic impact, for papers by Michael W. Lago Breakdown of academic impact, for papers by Tetsuo Asaki
Rankless by CCL
2026